Navigation Links
GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.

ProductsGeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor
Price $142.00
Description Ribonuclease Inhibitor is a recombinant protein that has been shown to help maintain the integrity of RNA in the preparation of cDNA by reverse transcription, in vitro RNA transcription, and in vitro protein synthesis. RNA Safe Inhibitor tightly binds RNases in a 1:1 ratio. It inhibits a broad range of eukaryotic RNases such as RNase A, RNase B, RNase C, and human placental RNase. RNA Safe does not interfere with the performance of other enzymes in the reaction. • RNA Safe is most effective between pH 5.5 and 8.0. It does not inhibit AMV or MMLV reverse transcriptases; SP6, T3, and T7 RNA polymerases; Taq DNA polymerase; RNase H; RNase T1; or S1 Nuclease. • Efficient inhibition of ribonucleases •Protects RNA during cDNA synthesis and in vitro transcription/translation.

  • Applications: First and second strand cDNA synthesis, RT-PCR, and in vitro transcription and translation.
  • Unit Definition: One unit of protein inhibits the activity of 5 ng RNase A by 50%.
  • Enzyme Concentration: 40 to 50 units/µl.
  • Supplied As: 5,000 units.
  • Storage Conditions: Store at -20°C.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
5. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
6. Recombinant RNasin® Ribonuclease Inhibitor from Promega
7. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
8. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
9. hERG-CHO K1 Recombinant Cell Line from Upstate
10. hERG-CHO K1 Recombinant Cell Line from Upstate
11. hHCN4-CHO K1 Recombinant Cell Line from Upstate
... 1,4-Dithiothreitol DTT White ... Purity: ≥99% by titration. Contaminants: ... mM, 1 cm, 260 nm): ≤0.500; (100 ... Heavy metals: ≤0.001%. Soluble in ...
... The Yeast Whole Genome ChIP-on-chip Microarray ... of yeast (S. cerevisiae) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
... of Salmonella genomes has allowed the development ... primer pairs. The S. enterica Typhimurium (strain ... (4,857,432 bp; 4,440 ORFs) and a plasmid, ... from Sigma-Genosys have been designed to amplify ...
... productivity and allows you to achieve a higher ... beyond traditional paper-based weighing processes into a powerful ... Control of ... PR, SR, PG-S, PG, SG, AT, MT, UMT, ...
Biology Products:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported today that ... total of 10,672,750 common share purchase warrants have been exercised ... the exercise of these warrants totalled $1,387,458 and 10,672,750 common ... ... expression of confidence by our warrant holders. This infusion of ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences ... Spain has been appointed as a Certified ... The IsoFlux system will be used in Genetracer Biotech,s ... to lung and colon cancer, with plans to move ... laboratory is utilizing Fluxion,s IsoFlux System to isolate, recover, ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
Breaking Biology Technology: